, Department of Clinical Pharmacology & Toxicology, University Hospital Basel, Switzerland & Regional Pharmacovigilance Centre Basel, University Hospital Basel, Switzerland & University of Basel, Basel, Switzerland, Switzerland

• Global Cardiology Science and Practice Vol. 2021 No. 2 (2021) - Pharmacovigilance
  Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre
  Abstract  PDF